Prostate Survival

my dad was recently diagnosed with prostate cancer. What are the survival rates? I've been hearing like 97% if it's caught early. is that true?

It depends on in which stage is his Cancer. Hope, he'll do well. Good luck!

2006-08-15 20:16:50 by whisper

Dendreon said its prostate cancer treatment Provenge prolonged patient survival, providing fuel for a rally in its shares.

is there any blog that gives the prostate cancer info about prostate cancer survival rate?

what the prostate cancer survival rate is like?
Phases of the development of prostate cancer is as follows:

A1 phase: the elderly may from time for processing. The chance of distant metastasis was 8%, 2% in the 5-10 years died from cancer.
A2 period: 30% distant metastasis, 20% in 5-10 years died from cancer.
B1 period: 30% in 5 years, metastasis, 20% died of prostate cancer.
B2 phase: 80% of 5-10 years, shift, 70% died of prostate cancer.
C period: 50% distant metastasis within 5 years, 75% died of cancer in 10 years.
D1 period: 85% distant metastasis within 5 years, the vast majority in three years, died of cancer.
D2 period: 50% in three years, died of prostate cancer, 80% in five years, died of cancer, 90% in 10 years, died of cancer.

http://prostatecancercom.com/the-stage-o f-prostate-cancer-survival-rate-would-li ke-to-know-about-the-prostate-cancer-sur vival-rate

2009-09-09 20:26:00 by rico

Price: $17.95

Thanks for Britain's CYA Report trying to explain the mitigating circumstances for Britain's Social Medicine's pathetic cancer track record. Kudos for that.

International Cancer Survival Rates are subject to numerous factors relating to comparisons based on definition and recording.

http://info.cancerresearchuk.org/news/be hindtheheadlines/europeancancersurvival/

Quote:

Dr Harry Burns, lead clinician for cancer in Scotland - the equivalent of England's newly appointed cancer tsar - said that figures showing higher death rates for Britain than Europe and America were not comparing like with like.

The system for registering cancer deaths is much tighter in Britain than elsewhere. A cancer patient who dies of a heart attack will be registered as a cancer death in the UK, while other countries' cancer registries tend to understate their death rates, Dr Burns said.

Eurocare II throws up oddities which cast doubt on the validity of the figures. The study, showing five-year survival rates from 1978 to 1989 for 17 countries, suggests Estonia has the best rate for certain cancers, above that of prosperous Germany and France.

It also shows that immigrants to Switzerland have a higher survival rate than the resident population - because most return to their home countries in their final months and their deaths are not recorded.

Separate evidence from international trials shows that British patients included in the trials do just as well as patients from other countries, casting doubt on the claims that treatment is less good in Britain.

Dr Burns said: "Until we have a properly designed study comparing like with like, it is daft and demoralising to say we do badly. There is no evidence that British patients are dying more frequently than they need to. We are underselling ourselves and it doesn't help public confidence."

His view was backed yesterday by Dr Peter Boyle, the director of epidemiology and biostatistics at the European Institute of Oncology in Milan. Dr Boyle said international comparisons could not be relied on because the disease might be more advanced at diagnosis in some countries than in others."There may well be differences [in survival] but we can't say whether they are due to treatment, diagnosis or something else. I don't think anyone knows the true position," he said.

Dr Boyle said global comparisons of this kind were meaningless: " Is spending money the key thing or is it spending it appropriately? We need to know the outcome of higher spending for individual patients, but that is difficult to assess."

The best cancer units in Britain provided care that was the equal of any in the world but the standard varied.

There were also regional differences in death rates. Dr Boyle said the best hope lay in the Calman-Hine proposals for spreading "best practice" by concentrating cancer care in specialist units linked to district hospitals.

"Calman-Hine was a huge breakthrough that put the patient, not the organisation, first. It has been very successfully implemented in Birmingham and Yorkshire.

It should ultimately lead to a better deal for patients," he said.

2009-08-02 12:29:29 by Ophelia

Price: $18.50

erm... Politician = false data.

2007-11-03 17:25:03 by CHUCK S

Hi. Survival rates for victims of prostate cancer are relatively high compared to most other types of cancer. Although there is some room for interpretation, generally, - for those men who have been tested early enough, the 10 year (or more) survival rate is an 80 - 90% value.

It is useful to break up prostate cancer victims into three main groups:

1) If the cancer has not extended beyond the prostate organ itself, the prognosis is best. Members of this group are most likely to find themselves in the high survival class.

2) If the cancer has extended beyond the prostate (e.g. to closely surrounding tissues, or near lymph nodes) there is still a very good likelihood of cure, defined as a 10 year survival rate.

3) If the cancer has extended (metastisized) to far site organs or tissues, i.e. bone, liver, lung or brain; - there is currently treatment on a palliative basis only. There is no known cure at this stage of the disease. If progressed this far, secondary bone cancer is the usual site of incidence.

It is VERY IMPORTANT to be tested as early as possible. The medical community recommends all men test annually after age 50, and that all men who have a relative with a history of prostate cancer test starting annually at age 40.
I SAY testing should start no later than age 30. The PSA blood test is not expensive, so if your medical insurance doesn't cover, YOU should be happy to pay up.

If a man tests later in life, and finds out then that he has prostate cancer, or worse that the cancer is of the aggressive form or has simply started out as the more usual slow prostate cancer, but has now has enough time to metastisize, - well then than man has been very unlucky indeed; and in my humble opinion has not been well served by the medical community's advice to test after 50 years of age.

I hope this answer has been of some help to you and your friend. Best regards,

2007-04-08 19:58:55 by Female